CONVERGE
CONVERGE: A target-focused platform for teams connecting patient biology to drug-development decisions. Ranked #19 of 30 in AI Drug Discovery Software by our editors (6.4/10); pricing: Pricing on request; best for teams prioritizing patient-relevant targets and biomarkers.
At a glance
- Editor score6.4 / 10
- PricingPricing on request
- Best forTeams prioritizing patient-relevant targets and biomarkers
- Free planNo
- Target identificationYes
- Founded2015 · San Francisco, California
- Facts checked4 Oct 2026
Where it wins
- Identifies and ranks candidate targets using human patient data
- Links targets and pathways to patient subgroups and molecular endotypes
- Evaluates preclinical models and candidate biomarkers against patient biology
Where it doesn't
- Focuses on target discovery, not molecule design
- Drug repurposing is not a documented capability
- Partner-facing applications and contact-form inquiries are not self-service
Our verdict on CONVERGE
CONVERGE is Verge Labs’ cloud platform for applying human disease biology to neuroscience drug development. It is aimed at mid-market and enterprise drug developers, rather than individual users seeking a self-service discovery tool. Its focus is target discovery and clinical-trial optimization: the platform identifies causal disease signatures and candidate targets from patient data, then connects those targets to patient subgroups that may respond.
A notable strength is the link between target analysis and patient context. CONVERGE characterizes target pathways across subgroups, stratifies trial populations by molecular endotype, and identifies candidate pharmacodynamic and disease biomarkers. It can also simulate biomarker changes under intervention and fine-tune models with program- and trial-specific data. These capabilities may suit teams that need to connect biological hypotheses with patient selection and biomarker planning; they do not make it a molecule-design suite.
The platform also assesses whether preclinical models recapitulate relevant patient biology and surfaces potential indication-expansion opportunities. Verge Labs says its models use proprietary multimodal CNS patient data, and its product materials describe partner-facing applications with inquiries directed through a contact form. According to the published product information, pricing is handled through sales contact rather than a listed self-service plan. Teams seeking patient-relevant target and trial insights may find the scope aligned with their work; those looking primarily for molecule design or drug repurposing should consider a different type of platform.
Your product? Our editors can test CONVERGE in depth and publish a review, labelled as paid · from $99/mo →
CONVERGE pricing
CONVERGE fact sheet
| Free plan | No |
|---|---|
| Paid from | Not verified |
| Target identification | Yes |
| Molecule design | No |
| Drug repurposing | No |
| Discovery scope | Target |
| Deployment options | Not verified |
| Research publications | Yes |
| Deployment | Cloud |
| Platforms | Web |
| Support | |
| Built for | Mid-market, Enterprise (editorial estimate) |
| Pricing | Pricing on request |
| Website | vergelabs.com |
| Facts checked | 4 Oct 2026 |
Alternatives to CONVERGE
- Amazon Bio DiscoveryA cloud workflow for designing, ranking, and testing antibody candidates.9.3
- Pharma.AIA broad discovery suite spanning target research, molecule design and clinical-trial prediction.8.8
- RecursionA broad discovery suite for teams connecting computational models with lab experiments.8.7
See all CONVERGE alternatives →
Used CONVERGE? Be the first to review it
The editor score above is our own research. What this page doesn't have yet is a reader's view — what you used CONVERGE for, what worked and what didn't. No stars are seeded and no review is paid for; an editor reads every one before it appears.
Write a reviewTwo minutes · verified accounts only · read by an editor before it appears
Featured on iTechGuides
CONVERGE is listed in our AI Drug Discovery Software directory. Add the badge to your site — it links back to this page.
<a href="https://www.itechguides.com/products/converge-ai-drug-discovery-platform/"><img src="https://www.itechguides.com/best/badge/converge-ai-drug-discovery-platform.svg" alt="Featured on iTechGuides" width="230" height="46"></a>
Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. How we rank.
Last updated · How we research and update